 Philadelphia, Pennsylvania and Oxfordshire, United Kingdom--Newsfile Corp. - October 27, 2022 - Adaptimmune Therapeutics plc NASDAQ: ADAP, a leader in cell therapy to treat cancer, will report financial results and provide business updates for the third quarter ended September 30, 2022, before the US markets open on Tuesday, November 8, 2022. Following the announcement, the Company will host a live teleconference and webcast at 8:00 a.m. EST 1:00 p.m. GMT that same day. 